英文名称: DTaP-HepB vaccine
中文名称: 预防乙肝病毒、白喉病毒、破伤风、百日咳病毒感染
通用名称: DTaP-HepB vaccine
商品名称: Eutravac
原研企业: LG Life Sciences
适应证: 预防乙型肺炎病毒感染,白喉、破伤风和百日咳
作用机制: 免疫刺激剂
原产地: 韩国LG生命科学 LG Life Sciences Ltd
Description Combined diphtheria, tetanus, acellular pertussis and r-DNA hepatitis B vaccine Suspension for injection in a vial Composition Each vial(0.5㎖) of Eutravac Inj. contains Diphtheria toxoid(≤16.7Lf), Tetanus toxoid(≤26.7㎍), Detoxified/purified Pertussis antigens(≥4IU) and purified HBsAg(10㎍) Indication Active primary immunization against diphtheria, tetanus, pertussis and hepatitis B infection Dosage and Administration 3 doses (1 dose = 0.5㎖) at 2, 4 and 6 months of age by intramuscular injection. Above schedule is the same when hepatitis B vaccine was already administered at birth. How supplied 0.5㎖/vial x 1, 10, 20, 50 vials Storage condition Store at 2~8℃ in hermetic container. Do not freeze.
Shelf life 30 months ------------------------------------------------- In the process, corporate value is being raised as we strive to attain our goal of being a top-tier pharmaceutical maker in the global market. Our involvement in pharmaceuticals dates back to 1981, when we began genetic engineering research as a division of LG Chemical. Since then, we have focused on the development of synthetic and bioengineered drugs, and we have enjoyed noteworthy success. For example, our quinolone antibiotic FACTIVE® became the first-ever new drug developed in Korea to receive FDA approval in 2003. It is now available in the US market and sales are growing steadily. The life sciences industry is committed to promoting human health and longevity. This business also represents unlimited possibilities and potential for growth. LG Life Sciences is contributing to the improvement of people health and life quality and is firmly established as the Korean leader of this strategically important industry. In the future, all LG Life Sciences employees will continue to strive for global prominence while operating as a highly ethical corporation that has the public trust. |